Palliative chemotherapy or watchful waiting? A vignettes study among oncologists

被引:44
作者
Koedoot, CG
de Haes, JCJM
Heisterkamp, SH
Bakker, PJM
de Graeff, A
de Haan, RJ
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Med Psychol, NL-1100 DE Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, NL-1100 DE Amsterdam, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol, NL-1100 DE Amsterdam, Netherlands
[4] Univ Amsterdam, Acad Med Ctr, Dept Biostat, NL-1100 DE Amsterdam, Netherlands
[5] Univ Amsterdam, Med Ctr, Dept Internal Med, Amsterdam, Netherlands
关键词
D O I
10.1200/JCO.2002.12.012
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To determine the preferences of oncologists for palliative chemotherapy or watchful waiting and the factors considered important to that preference. Methods: Sixteen vignettes (paper case descriptions), varying on eight patient and treatment characteristics, were designed to assess the oncologists' preferences. Their strength of preference was rated on a 7-point scale. An orthogonal main effects design provided a subset of all possible combinations of the characteristics, allowing estimations of the relative weights of the presented characteristics. A written questionnaire was sent to a random sample of oncologists (N = 1,235). Results: The response rate was 67%, and 697 questionnaires were available for analysis. Eighty-one percent of the respondents were male. The mean age was 46 years. We found considerable variation among the oncologists. No major associations between physician characteristics and preferences were found. Of the patient and treatment characteristics affecting treatment preference, age was the strongest predictor, followed by the patient's wish to be treated and the expected survival gain. Other patient and treatment characteristics had a limited effect on preferences, except for psychologic distress, which had no independent impact. Conclusion: Patients will encounter different decisions depending on their oncologists' preferences and their own personal background. Therefore, to ensure adequate information for decision-making processes, decision aids are proposed. (C) 2002 by American Society of Clinical Oncology.
引用
收藏
页码:3658 / 3664
页数:7
相关论文
共 49 条
[1]  
[Anonymous], LIFE DEATH DECISIONS
[2]  
BARRAS JM, 2001, BRIT MED J, V322, P1
[3]   PATIENT REACTIONS TO A PROGRAM DESIGNED TO FACILITATE PATIENT PARTICIPATION IN TREATMENT DECISIONS FOR BENIGN PROSTATIC HYPERPLASIA [J].
BARRY, MJ ;
FOWLER, FJ ;
MULLEY, AG ;
HENDERSON, JV ;
WENNBERG, JE .
MEDICAL CARE, 1995, 33 (08) :771-782
[4]   Doing nothing is no choice: lay constructions of treatment decision-making among women with early-stage breast cancer [J].
Charles, C ;
Redko, C ;
Whelan, T ;
Gafni, A ;
Reyno, L .
SOCIOLOGY OF HEALTH & ILLNESS, 1998, 20 (01) :71-95
[5]   Shared decision-making in the medical encounter: What does it mean? (Or it takes at least two to tango) [J].
Charles, C ;
Gafni, A ;
Whelan, T .
SOCIAL SCIENCE & MEDICINE, 1997, 44 (05) :681-692
[6]   Decision-making in the physician-patient encounter: revisiting the shared treatment decision-making model [J].
Charles, C ;
Gafni, A ;
Whelan, T .
SOCIAL SCIENCE & MEDICINE, 1999, 49 (05) :651-661
[7]   DECISION-MAKING DURING SERIOUS ILLNESS - WHAT ROLE DO PATIENTS REALLY WANT TO PLAY [J].
DEGNER, LF ;
SLOAN, JA .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1992, 45 (09) :941-950
[8]   Does palliative chemotherapy palliate? Evaluation of expectations, outcomes, and costs in women receiving chemotherapy for advanced ovarian cancer [J].
Doyle, C ;
Crump, M ;
Pintilie, M ;
Oza, AM .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (05) :1266-1274
[9]   EFFECT OF PATIENTS EXPECTATIONS OF BENEFIT WITH STANDARD BREAST-CANCER ADJUVANT CHEMOTHERAPY ON PARTICIPATION IN A RANDOMIZED CLINICAL-TRIAL - A CLINICAL VIGNETTE STUDY [J].
FETTING, JH ;
SIMINOFF, LA ;
PIANTADOSI, S ;
ABELOFF, MD ;
DAMRON, DJ ;
SARSFIELD, AM .
JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (09) :1476-1482
[10]   Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer [J].
Fowler, FJ ;
Collins, MM ;
Albertsen, PC ;
Zietman, A ;
Elliott, DB ;
Barry, MJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (24) :3217-3222